Yes. Insulin glargine biosimilars are USD 15–30 per vial vs USD 100+ US private pay. Modern rapid-acting analogues (lispro, aspart) similarly priced. Insulin pump and CGM access is available with appropriate prescribing.
Have a follow-up question?
Reply via the quote wizard with case-specific questions and a coordinator will answer in 1–2 business days.